| CAPITAL GROUP EMERGING MARKETS EQUITY FUND (LUX) A7 USD | RVI EMERGENTES | 166,130264 | 15/10/2026 | 22,90% | 57,52% | ** |
| CAPITAL GROUP FUTURE GENERATIONS GLOBAL OPPORTUNITIES FUND (LUX) SH USD | RVI GLOBAL | 13,743487 | 15/10/2026 | 22,90% | · | ND |
| GOLDMAN SACHS MULTI-MANAGER EMERGING MARKETS EQUITY PORTFOLIO P DIS USD | RVI EMERGENTES | 16,452534 | 15/10/2026 | 22,90% | 65,06% | *** |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | RVI BIOTECNOLOGÍA | 69,985724 | 15/10/2026 | 22,90% | 36,24% | ** |
| STATE STREET SPDR MSCI EM ASIA UCITS ETF | RVI ASIA EX-JAPÓN | 107,761510 | 15/10/2026 | 22,90% | 71,29% | **** |
| VERITAS ASIAN FUND A EUR CAP | RVI ASIA EX-JAPÓN | 926,347600 | 15/10/2026 | 22,90% | · | ND |
| BARINGS ASIA GROWTH FUND A EUR INC | RVI ASIA EX-JAPÓN CRECIMIENTO | 157,870000 | 15/10/2026 | 22,89% | 67,29% | *** |
| BARINGS GLOBAL EMERGING MARKETS FUND I USD CAP | RVI EMERGENTES | 70,396146 | 15/10/2026 | 22,89% | 69,57% | **** |
| FIDELITY FUNDS 2 - FOCUSED STOCK FUND SE-ACC-USD | RVI USA | 10,421128 | 15/10/2026 | 22,89% | · | ND |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | RVI BIOTECNOLOGÍA | 119,370093 | 15/10/2026 | 22,89% | 36,53% | ** |
| NORDEA 1-ASIA EX JAPAN EQUITY FUND AP-EUR | RVI ASIA EX-JAPÓN CRECIMIENTO | 35,591500 | 15/10/2026 | 22,89% | 56,11% | * |
| ROBECO EMERGING MARKETS EQUITIES F USD | RVI EMERGENTES | 226,846895 | 15/10/2026 | 22,89% | 77,54% | **** |
| BLACKROCK SYSTEMATIC GLOBAL EQUITY ABSOLUTE RETURN X2 USD | RENT. ABSOLUTA. | 207,878301 | 15/10/2026 | 22,88% | 58,15% | ***** |
| POLAR CAPITAL NORTH AMERICAN I GBP DIS | RVI USA | 53,539771 | 15/10/2026 | 22,88% | 60,31% | ** |
| SCHRODER ISF GLOBAL EMERGING MARKET OPPORTUNITIES B ACC USD | RVI EMERGENTES | 25,866345 | 15/10/2026 | 22,88% | 72,93% | **** |
| T.ROWE GLOBAL NATURAL RESOURCES EQUITY FUND I | RVI MATERIAS PRIMAS | 20,958244 | 15/10/2026 | 22,88% | 34,16% | * |
| COMGEST GROWTH ASIA EUR ACC | RVI ASIA PACÍFICO | 15,310000 | 15/10/2026 | 22,87% | · | ND |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 86,720000 | 15/10/2026 | 22,87% | 37,45% | ** |
| SANTANDER FUTURE WEALTH AE CAP | RVI GLOBAL | 130,525800 | 15/10/2026 | 22,87% | 53,18% | * |
| UBS (LUX) KEY SELECTION SICAV - GLOBAL EQUITY VALUE OPPORTUNITY (USD) P-ACC | RVI GLOBAL VALOR | 140,114204 | 15/10/2026 | 22,87% | · | ND |
